NCT01393899 The Safety And Efficacy Of Maintenance Therapy With CP-690,550 Status COMPLETED Phase PHASE2
NCT01393626 A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease Status COMPLETED Phase PHASE2
NCT01392365 Development of a Prediction Model for Differential Diagnosis Between Intestinal Tuberculosis and Crohn's Disease Status COMPLETED Phase N/A
NCT01388933 A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease Status TERMINATED Phase PHASE2
NCT01387594 Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFs Status COMPLETED Phase PHASE1
NCT01372969 Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease. Status COMPLETED Phase PHASE1/PHASE2
NCT01369355 A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI) Status COMPLETED Phase PHASE3
NCT01369342 A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2) Status COMPLETED Phase PHASE3
NCT01369329 A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1) Status COMPLETED Phase PHASE3
NCT01355614 A Phase II Efficacy Study in Fistulizing Crohn's Disease Patients Status COMPLETED Phase PHASE2
NCT01352221 Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2) Status COMPLETED Phase PHASE3
NCT01349504 Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease Status COMPLETED Phase N/A
NCT01346826 Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD) Status COMPLETED Phase PHASE4
NCT01341808 Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients Status COMPLETED Phase PHASE4